Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Artificial Reddener

19.10.2009
New synthetic route for EPO and other glycoprotein analogues

Erythropoetin, abbreviated EPO, has gained a scandalous reputation as a doping agent for racing cyclists. The name is derived from the ancient Greek erythros “red” and poiein “to make”, a fitting designation for this important growth factor, which is responsible for the formation of red blood cells in the body.

Biotechnologically produced erythropoetin, aside from its implementation as a drug for cyclists, is primarily used to treat anemia in dialysis patients after aggressive chemotherapy. A Japanese and British team led by Yasuhiro Kajihara has now successfully produced analogues of this factor in a synthesis that is half biotechnological and half chemical. As the researchers report in the journal Angewandte Chemie, this synthetic route could be an attractive general approach for the production of glycoproteins—proteins that have side-chains of sugar building blocks.

EPO is a well-investigated glycoprotein with a known, clearly delineated biological function. It is thus favored as a model glycoprotein. Its protein component is made of 166 amino acids, and four complex sugar chains (oligosaccharides) are bound to it like branched antennas. They increase the lifetime of the protein in the blood.

Glycoproteins are important pharmacological agents; however, they are difficult to produce. In cell cultures, no uniform saccharide chains are formed. In addition, bacteria are not able to recreate the complex oligosaccharides found in mammals. The alternative approach, chemical synthesis, is capable of producing tailored, uniform glycoproteins that can fulfill the function of glycoproteins as drugs and for research. However, this approach is very expensive.

The team has found a happy medium: they used a biotechnology approach to produce only one part of the EPO protein chain in a bacterial culture. They used chemical synthesis to produce the second, shorter part of the protein chain with the sugar antennas. They introduced a synthetic anchoring site, to which sugars can be chemically attached. The saccharide used was a branched complex sialyloligosaccharide from egg yolks. In the final step, the researchers hooked together the two protein chains by a method known as native chemical ligation.

Folding experiments demonstrated that, like natural EPO, the synthetic EPO analogue assumes a helical structure. Cell proliferation assays with bone marrow cells yielded a biological activity equal to that of the original. In vivo, the analogue could not increase the red-blood-cell count in the same way as true EPO. The researchers hope that by using different, more highly branched oligosaccharides they will be able to create analogues that also demonstrate high bioactivity in vivo.

Author: Yasuhiro Kajihara, Yokohama City University (Japan), mailto:kajihara@chem.sci.osaka-u.ac.jp

Title: Design and Synthesis of a Homogeneous Erythropoietin Analogue with Two Human Complex-Type Sialyloligosaccharides: Combined Use of Chemical and Bacterial Protein Expression Methods

Angewandte Chemie International Edition, doi: 10.1002/anie.200904376

Yasuhiro Kajihara | Angewandte Chemie
Further information:
http://www.chem.sci.osaka-u.ac.jp
http://pressroom.angewandte.org

More articles from Life Sciences:

nachricht Cancer diagnosis: no more needles?
25.05.2018 | Christian-Albrechts-Universität zu Kiel

nachricht Less is more? Gene switch for healthy aging found
25.05.2018 | Leibniz-Institut für Alternsforschung - Fritz-Lipmann-Institut e.V. (FLI)

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>